JAMA Cardiology

JAMA Cardiology

JAMA CARDIOL
影响因子:14.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:American Medical Association
发刊时间:0
发刊频率:
收录数据库:SCIE/Scopus收录
ISSN:2380-6583

期刊介绍

JAMA Cardiology is an international peer-reviewed journal and the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide. JAMA Cardiology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
JAMA Cardiology是一本国际同行评审期刊,也是全球心血管医学临床研究者、临床医生和实习生的权威期刊。JAMA Cardiology是JAMA网络的成员,JAMA网络是一个由同行评审的全科医学和专业出版物组成的联盟。
年发文量 118
国人发稿量 2.67
国人发文占比 0.02%
自引率 -
平均录取率-
平均审稿周期 -
版面费 -
偏重研究方向 Medicine-Cardiology and Cardiovascular Medicine
期刊官网 https://jamanetwork.com/journals/jamacardiology
投稿链接 https://manuscripts.jamacardio.com/cgi-bin/main.plex

期刊高被引文献

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1880
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2018.4936
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1391
Cardiovascular Risk Factors Associated With Venous Thromboembolism
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2018.4537
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.0014
Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1041
Association of Biologic Therapy With Coronary Inflammation in Patients With Psoriasis as Assessed by Perivascular Fat Attenuation Index.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2589
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2467
Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2018.4566
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.0179
Temporal Changes in Coronary Hyperemic and Resting Hemodynamic Indices in Nonculprit Vessels of Patients With ST-Segment Elevation Myocardial Infarction.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2138
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.0849
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.0886
Temporal Trends and Patterns in Mortality After Incident Heart Failure
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.3593
Association of Conventional Cardiovascular Risk Factors With Cardiovascular Disease After Hypertensive Disorders of Pregnancy
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.1746
Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1647
Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2202
Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.0175
Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With Gout.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3201
Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction-Reply.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2018.4843
Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses From a Randomized Clinical Trial.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2074
Association of Transient Endothelial Dysfunction Induced by Mental Stress With Major Adverse Cardiovascular Events in Men and Women With Coronary Artery Disease.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3252
Association of Mild Echocardiographic Pulmonary Hypertension With Mortality and Right Ventricular Function.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3345
Patient and Hospital Characteristics of Mitral Valve Surgery in the United States.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3659
Optimal Combination of Compression Rate and Depth During Cardiopulmonary Resuscitation for Functionally Favorable Survival.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2717
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.0302
Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2019.0198
Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.0535
Current Demographic Status of Cardiologists in the United States.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3247
Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3773
New Directions in Right Ventricular Assessment Using 3-Dimensional Echocardiography.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2424
Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2845
Association of Region and Hospital and Patient Characteristics With Use of High-Intensity Statins After Myocardial Infarction Among Medicare Beneficiaries.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2481
Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2018.4472
Association of Multifaceted Mobile Technology-Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2974
Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3113
Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.4296
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Sacubitril/Valsartan and Ivabradine in Heart Failure.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.4982
Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil: The BRIDGE Cardiovascular Prevention Cluster Randomized Clinical Trial.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.0649
Palliative Inotrope Therapy: A Narrative Review.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2081
Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention: A Systematic Review of Randomized Clinical Trials.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3066
Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1960
Weight Gain, Hypertension, and the Emergence of a Maladaptive Cardiovascular Phenotype Among US Football Players.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.3909
Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.0529
Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.4513
Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations
来源期刊:JAMA CardiologyDOI:10.1001/jamacardio.2018.4717
Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1856
Association Between Change in Circulating Progenitor Cells During Exercise Stress and Risk of Adverse Cardiovascular Events in Patients With Coronary Artery Disease.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.4528
Error in Axis Labels in Figure.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.2328
Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals.
来源期刊:JAMA cardiologyDOI:10.1001/jamacardio.2019.1755

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
95.76%15.27%-19.14%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
CARDIAC & CARDIOVASCULAR SYSTEMS
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学1区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
1区
2023年12月升级版
医学1区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
1区
2022年12月旧的升级版
医学1区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
1区